BindingDB logo
myBDB logout

49 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28011425 92 Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.EBI University of Auckland
28003141 65 Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.EBI Bristol-Myers Squibb Research and Development
28523098 28 INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology.EBI Incyte Corporation
28280261 84 Non-kinase targets of protein kinase inhibitors.EBI The University of Sydney
27994758 130 Fused Heterocyclic Compounds as Potent Indoleamine-2,3-dioxygenase 1 Inhibitors.EBI Indian Institute of Technology
27769672 2 Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.EBI Xihua University
26717206 64 O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1.EBI Bryn Mawr College
26653033 27 Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.EBI National Health Research Institutes
26642377 22 Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.EBI National Health Research Institutes
26348881 54 Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening.EBI National Health Research Institutes
26207924 32 Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.EBI Colorado College
25264478 6 Indoleamine 2,3-dioxygenase inhibitors: potential treatment for cancer, sepsis, and more.EBI Therachem Research Medilab (India) Pvt. Ltd.
25036789 45 Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.EBI Swiss Institute of Bioinformatics
24939758 72 Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.EBI National Health Research Institutes
25313323 23 Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors.EBI Dainippon Sumitomo Pharma Co., Ltd.
24878638 32 Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.EBI University of Namur (UNamur)
24262887 11 Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).EBI University of Auckland
24099220 40 Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.EBI Fudan University
23337802 21 Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI Toho University
23218716 20 Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A.EBI University of Namur
23521768 3 Aminophenoxazinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis of exfoliazone and chandrananimycin A.EBI University of Nottingham
22873824 4 Halicloic acids A and B isolated from the marine sponge Haliclona sp. collected in the Philippines inhibit indoleamine 2,3-dioxygenase.EBI University of British Columbia
22616902 165 Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.EBI Ludwig Center for Cancer Research of the University of Lausanne
22304006 1 Antiproliferative activity of trans-avicennol from Zanthoxylum chiloperone var. angustifolium against human cancer stem cells.EBI Universit£ Paris-Sud
21726069 98 Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.EBI University of Namur
20688518 84 S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.EBI University of Shizuoka
20055453 80 Rational design of indoleamine 2,3-dioxygenase inhibitors.EBI Institute for Cancer Research
19507862 42 Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.EBI Incyte Corporation
22112538 22 Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.EBI Macquarie University
21925773 22 Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI Fudan University
21419531 3 Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI University of Namur
21391610 139 Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.EBI Vertex Pharmaceuticals (Europe) Ltd.
21269836 27 Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.EBI University of Namur
20580138 17 Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.EBI Gyeongsang National University
18677305 3 Biomimetic synthesis of the IDO inhibitors exiguamine A and B.EBI University of California
18715787 5 Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.EBI The University of Tokushima
17067170 9 Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.EBI University of British Columbia
21867918 4 Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus.BDB The University of Chicago
21700210 6 Identification of a small-molecule inhibitor of DNA topoisomerase II by proteomic profiling.BDB RIKEN Advanced Science Institute
995128 168 Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.BDB TBA
17656313 14 Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases.BDB The Johns Hopkins University
19143569 36 Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer.BDB Abbott Laboratories
18234496 12 Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).BDB Bristol-Myers Squibb Company
18590272 33 Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.BDB University of Bath
15537346 15 Design of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 1.BDB University of Oxford
16451058 16 Structural Insight into the Stereoselective Inhibition of MMP-8 by Enantiomeric Sulfonamide Phosphonates.BDB Istituto di Cristallografia
8021916 11 Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.BDB Bristol-Myers Squibb Company